Immunomodulation of experimental autoimmune uveoretinitis:A model of tolerance induction with retinal antigens

Eye (Basingstoke)

Volumn 8, Issue 1, 1994, Pages 52-59

  Dick, A D ^a   Cheng, Y F ^a   Liversidge, J ^a   Forrester, J V ^a  

^a NONE   (United Kingdom)

Author keywords

Experimental autoimmune uveoretinitis (EAU); Immunomodulation; Intranasal tolerance; Tolerance; Uveoretinitis

Indexed keywords

RETINA ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; HELPER CELL; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; RAT; UVEITIS; UVEORETINITIS;

EID: 0028325939     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.1994.10     Document Type: Article

References (66)

1. Forrester JV. Endogenous posterior uveitis. Br J Ophthalmol 1990;74:620-3.
2. Forrester JV, Liversidge J, Dua HS, Towler H, Mc Menamin PG. Comparison of clinical and experimental uveitis. Curr Eye Res 1990;9:75-84.
3. Forrester JV. Uveitis: pathogenesis. Lancet 1991;388: 1489-501.
4. Towler HM, Cliffe AM, Whiting P, Forrester JV. Low dose cyclosporin A and steroid therapy. Eye 1989;3:282-7.
5. Towler HM, Whiting PH, Forrester JV. Combination of low dose CsA and steroid therapy in chronic intraocular inflammation. Eye 1990;4:514-20.
6. Towler HM, Lightman SL, Forrester JV. Low dose CsA therapy of ocular inflammation: preliminary report of a long term follow up study. Autoimmunity 1992;5:259-64.
7. Granelli-Pipema A. In situ hybridisation for interleukin 2 receptor mRNA in T-cells activated in the presence or absence of CsA. J Exp Med 1988;5:1649-58.
8. Kawashima M, Mochizuki M. Effects of a new immunosuppressive agent FK 506 on the efferent limb of the immune response. Exp Eye Res 1990;51:565-72.
9. Mochizuki M, Iheda A, Shira O, Jukito S, Yoshimura K, Shi-mada N. Preclinical and clinical study of FK 506 in uveitis. Curr Eye Res 1992; 11:87-97.
10. deKozak Y, Sakai J, Thillaye B, Faure JP. S-Ag induced experimental autoimmune uveoretinitis in rats. Curr Eye Res 1981;1:327-40.
11. Fox GM, Kuwabara T, Wiggert B, Redmond TM, Hess HH, Chader GJ, Gery I. EAU induced by IRBP: difference between EAU induced by IRBP and S-Ag. Clin Immunol Immunopathol 1987;43:256-64.
12. Si SJ, Borst DE, Redmond TM. Nickerson JM. Cloning of cDNA encoding human IRBP and comparison with bovine IRBP sequences. Gene 1989;80:99-109.
13. Shinohara T, Dietachold B, Donoso LA, Howitz J, Tao R. A primary and secondary structure of bovine retinal S-Ag (48 Kd protein). Proc Natl Acad Sci USA 1987;84:6975-9.
14. Gery I, Mochizuki M, Nussenblatt R. Retinal specific antigens and the immunopathogenic process they provoke. Prog Retinal Res 1986;5:75-109.
15. Broekhuyse RM, Kulhman ED, Winkens NJ, Van Vogt AHM. Experimental allergic anterior uveitis: a new form of experimental uveitis. Induction by a detergent-insoluble intrinsic protein fraction of the retinal pigment epithelium. Exp Eye Res 1991;52:465-74.
16. Broekhuyse RM, Kulhman ED, Winkens HJ. Experimental allergic posterioruveitis accompanied by epithelial cell accumulations (EAPU): a new type of experimental ocular disease induced by immunisation with PEP-65, a pigment epithelial polypeptide preparation. Exp Eye Res 1992;55: 819-26.
17. Dua HS, Lee RH, Lolley RN, Barrett JA, Abrams M, Forrester JV, Donoso PA. Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin. Curr Eye Res 1992; 11: I 07-12.
18. Faure JP. Autoimmunity and the retina. Curr Eye Res 1980; 2:215-301.
19. Forrester JV, Borthwick GM, McMenamin PG. Ultrastruc-tural pathology of S-Ag uveoretinitis. Invest Ophthalmol Vis Sci 1985;26:1281-92.
20. Harper FH, Liversidge J, Thompson AW, Forrester JV. Interphotoreceptor retinal binding protein induced EAU: an immunophenotypic analysis using alkaline phosphatase anti-alkaline phosphatase staining, dual immunofluorescence and confocal microscopy. Curr Eye Res 1992; 11: 129-34.
21. Lightman SL, Yuen L. Relationship of blood retinal barrier breakdown to lymphocytic infiltration in EAU. Invest Ophthalmol Vis Sci 1990;31:51 1-9.
22. Liversidge J, Forrester JV. Experimental autoimmune uveoretinitis: immunophenotypic analysis of inflammatory cells in chorioretinal lesions. Curr Eye Res 1988;7: 1231-41.
23. Caspi RR, Roberge FG, McAllister CG, El-Said M, Kuwabara T, Gery I, et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 1986; 136:928-33.
24. Nussenblatt RB, Cevario SJ, Gery I. Altered suppressor cell activity in uveitis. Lancet 1980;2:722.
25. Nussenblatt RB. Experimental autoimmune uveoretinitis: mechanisms of disease and clinical therapeutic indications. Invest Ophthalmol Vis Sci 1991;32:3131-40.
26. Hirose S, Oasawara K, Natori T, Sasamoto Y, Ohno S, Mat-suda H, Onoe K (1991) Regulation of experimental autoimmune uveitis in rats: separation of MHC and non-MHC gene effects. Clin Exp Immunol 1991;86:419-25.
27. Holt PG, McMenamin C. Defence against allergic sensitisation in the healthy lung: the role of inhalational tolerance. Clin Exp Allergy 1989;19:255-62.
28. Linthicum DS, Munoz JJ, Blassett A. Acute EAE in mice: adjuvant action of Bordetella pertussis is due to vasoactive amine sensitisation and increased permeability of the CNS. Cell Immunol 1982;73:299.
29. Hiroshima M, Yodoi J, Ishizaka K. Formation of IgE binding factors by rat T-lymphocytes: mechanisms of selective foonation of IgE potentiating factors by treatment with Bordetella pertussis vaccine. J Immunol 1981;127:1804-9.
30. Kamrandt T, Soloway PD, Perkins DL, Gefter ML. Pertussis toxin prevents the induction of peripheral T-cell anergy and enhances T-cell response to an encephalogenic peptide of myelin basic protein. J Immunol 1991;147:3296-302.
31. Dick AD, Cheng YF, Mc Kinnon A, Liversidge J, Forrester JV. Nasal administration of retinal antigens suppresses the inflammatory response in experimental autoimmune uveo-retinitis: a preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 1993;77: 171-5.
32. Dua HS, Sewell H, Forrester JV The effect of retinal S-Ag specific monoclonal antibody therapy on experimental autoimmune uveoretinitis and experimental autoimmune pineal-itis. Clin Exp Immunol 1989;75:100-5.
33. Dua HS, Liversidge J, Forrester JV Immunomodulation of experimental autoimmune uveitis using a rat anti-retinal S-antigen specific monoclonal antibody: evidence for a species difference. Eye 1989;3:69-78.
34. DeKozak Y, Mirshahi M, Boucheix C. Faure JP, Letts LG, Rothlein R. Prevention of experimental autoimmune uveoretinitis by active immunisation with autoantigen-specific monoclonal antibodies. Eur J Immunol 1990;17:541-7.
35. Dua HS, Abrams M, Barrett JA, Gregerson DS, Forrester JV, Donoso LA. Epitopes and idiotypes in experimental autoimmune uveoretinitis: a review. Curr Eye Res 1992; 11: 59-66.
36. Sakai K, Zamvill SS, Mitchell DJ, Hodgkinson S, Rothbard JB, Steinrnan L. Prevention of experimental allergic encephalomyelitis with peptides that block interaction of T-cells with major histocompatibility complex protein. Proc Natl Acad Sci USA 1989;86:9470-4.
37. Wetzig R, Hooks JJ, Percopo CM, Nussenblatt R, Chan CC, Detrick B. Anti-Ia antibody diminishes ocular inflammation in experimental autoimmune uveoretinitis. Curr Eye Res 1988;7:809-18.
38. Atalla L, Linker-Israeli M, Steinman L, Rao NA. Inhibition of autoimmune uveitis by anti CD4 antibody. Invest Ophthalmol Vis Sci 1990;31:7-11.
39. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Eur J Immunol 1992; 10: 561-91.
40. Dua HS, McKinnon A, McMenamin PG, Forrester JV Ultrastructural pathology of barrier sites in experimental autoimmune uveitis and experimental autoimmune pineal-itis. Br J Ophthalmol 1991;75:391-7.
41. Mc Menamin PG, Forrester JV, Steptoe RJ, Dua HS. Ultra-structural pathology of experimental autoimmune uveitis: quantitative evidence of HEV-like changes in the retinal vascular endothelium. Lab Invest 1992;67:42-65.
42. Liversidge J, Forrester JV Are accessory molecules implicated in activation of T-cells at the blood retinal barrier? Curr Eye Res 1990;9:131-9.
43. Liversidge J, Sewell H, Forrester JV Interactions between lymphocytes and cells of the blood retinal barrier: mechanisms of T-lymphocyte adhesion to human capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology 1990;71:390-6.
44. Liversidge J, Thomson AWE, Forrester JV FK 506 modulates accessory cell adhesion molecule expression and inhibits CD4 lymphocyte adhesion to retinal pigment epithelial cells in vivo: implications for therapy of uveoretinitis. Transplant Proc 1991;23:3339-405.
45. Powell D, McKnight AJ, Powrie F. Dycke R, Mason D. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev 1991;123:37-64.
46. Roberge FG, Lorberboum-Galski H, Le Hoange P, deSmet M, Chan CC, Fitzgerald D, Pastan I. Selective immune suppression of activated T-cells with chimeric toxin IL2-PE40: inhibition of experimental autoimmune uveoretinitis. J Immunol 1989;143:3498-502.
47. Kaplan HJ, Streilein JW. Immune response to immunisation via the anterior chamber of the eye. J Immunol 1977;118: 809-14.
48. Streilin JW, Wilbanks GA, Taylor A, Cousins S. Eye derived cytokines and the immunosuppressive intraocular micro environment: a review. Curr Eye Res 1992;11:41-7.
49. Barton K., Hu XS, Zhao ZS, Calder VS, Lightman SL. Transforming Growth Factor-b as a therapeutic agent in ocular inflammation [abstract]. Congress of College of Ophthalmologists 1993.
50. Dua HS, Gregerson DS, Donoso LA. Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells. Cell Immunol 1992;139: 292-305.
51. Jenkins MC, Schwartz RH. Antigen presentation by chemically modified splenocytes induced antigen specific T-cell unresponsiveness in vitro and in vivo. J Exp Med 1987;165: 302-19.
52. Holt PG, Sedgwick J. Suppression of IgE responses fct1-lowing inhalation of antigens. Immunol Today 1987;8:14-5.
53. Mowat AM. The regulation of the immune responses to dietary protein antigens. Immunol Today 1987;8:93-5.
54. Stephen H, Thompson G, Staines NA. Could specific oral tolerance be a therapy to autoimmune disease? Immunol Today 1990;11:396-9.
55. Nussenblatt RB, Caspi RR, Mahdi R, Chan CC, Roberge F, Lider O, et al. Inhibition of S-Ag induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-Ag. J Immunol 1990;144:1689-95.
56. Vrabec TR. Gregerson DS, Dua HS, Donoso LA. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-Ag and synthetic peptides. Autoimmunity 1992; 12:175-84.
57. Lider O, Santos LMB, Lee CYS, Higgins PJ, Weiner HL. Suppression of EAE by oral administration of myelin basic protein: suppression of the disease, in vitro immune responses is mediated by Ag-specific CD8+ T cells. J Immunol 1988;142:748-53.
58. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA. Double blind pilot trial of oral tolerance with myelin antigens in multiple sclerosis. Science 1993;259: 1321-4.
59. Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu A, Trotter JL, Miller SD. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalogenic peptides. J Immunol 1990;144:905-15.
60. Friedman A, Malamed D. Relationship between tolerogenic and immunogenic signals in a T-lymphocyte immune response [abstract]. Proc Int Congress of Immunology 1992; 552.
61. Holt PG, Schon-Hegrad MA, Oliver J, Holt BJ, Mc Menamin PG. A contiguous network of dendritic antigen presenting cells within the respiratory epithelium. Int Arch Allergy Appllmmunol 1990;91:155-9.
62. Shastri N, Miller A, Sercarz EE. Amino acid residues distant from the determinant region can profoundly affect activation of T-cell clones by related antigens. J Immunol 1986; 136:371-9.
63. Levine TP, Chain BM. The cell biology of antigen processing. Crit Rev Biochem Mol Biol 1991;26:439-73.
64. Mosmann TR, Coffman RL. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-51.
65. Bloom BR, Salgome P, Diamond B. Revisiting and revising suppressor T-cells. Immunol Today 1992;13:131-6.
66. Maggi E, Parranchi P, Mazetti R, et al. Reciprocal regulatory effects of IFN-y and IL-4 on the in vitro development of human Thl and Th2 clones. J Immunol 1992;148: 2142-7.